Диссертация (1174378), страница 18
Текст из файла (страница 18)
- № 2. P. 294-308.61. Fedulov A. Immunostimulatory CpG oligonucleotides abrogate allergicsusceptibility in a murine model of maternal asthma transmission / A. Fedulov, E.Silverman, Y. Xiang, A. Leme, L. Kobzik // The Journal of Immunology. - 2005. - Vol.175. - № 7. - P.
4292-4300.62. Ferreira D. S. Toll-like receptors, 3 and 4 and thymic stromal lymphopoietinexpression in fatal asthma / D. S. Ferreira, R. Annoni, L F. Silva, M. Buttignol, A. B.Santos, M. C. Medeiros, L. N. Andrade, C. Y. Yick, P. J. Sterk, J. L. Sampaio, M.Dolhnikoff, S. E. Wenzel, T. Mauad // Clin Exp Allergy. - 2012.
- Vol. 42. - № 10. - P.1459-1471.63. Ganz T. Defensins: antimicrobial peptides of innate immunity / T. Ganz // NatureReviews Immunology. - 2003. - Vol. 3. - P. 710-720.64. Gaudieri S. Genetic variations in IL28B and allergic disease in children / S.Gaudieri, M. Lucas, A. Lucas, E. McKinnon, H. Albloushi, A. Rauch, J. di Iulio, D.110 Martino, S.L.
Prescott, M.K. Tulic // PLoS One. - 2012. - Vol. 7. - № 1. - Article IDe30607.65. Gaudieri S. IFN-λ and IgE-mediated allergic disease: a potential future role? / SGaudieri, M. Tulic // Biomarkers Med. - 2012. - Vol. 6. - № 2. - Р. 151-157.66. Goulopoulou S. Toll-like receptors in the vascular system: sensing the dangerswithin / S. Goulopoulou, C.G. McCarthy, R.C.
Webb // Pharmacological Reviews. 2016. - Vol. 68. - № 1. - P. 142-167.67. Gauvreau G.M. Effects of an anti-TSLP antibody on allergen-induced asthmaticresponses / G.M. Gauvreau, P.M. O’Byrne, L.P. Boulet, Y. Wang, D. Cockcroft, J.Bigler, J.M. FitzGerald, M. Boedigheimer, B.E. Davis, C. Dias, K.S. Gorski, L. Smith,E. Bautista, M.R. Comeau, R. Leigh, J.R. Parnes // N Engl J Med. - 2014. - Vol. 370. № 22. - P. 2102-2110.68.
Gehlhar K. Impaired virus-induced interferon-α2 release in adult asthmaticpatients / K. Gehlhar, C. Bilitewski // Clinical and Experimental Allergy. - 2006. - Vol.36. - Р. 331-333.69. Gina Global Strategy For Asthma Management And Prevention / Gina // Glob.Initiat. Asthma – 2016.70. Gina Global Strategy For Asthma Management And Prevention / Gina // Glob.Initiat. Asthma – 2018.71. Grissell T.V. Interleukin-10gene expression in acute virus-induced asthma / T.V.Grissell, H.Powell, D.R. Shafrenetal // American Journal of Respiratory and CriticalCare Medicine. - 2005. - Vol. 172.
- Vol. 4. - P. 433-439.72. Hammad H. Barrier epithelial cells and the control of type 2 immunity / H.Hammad, B.N. Lambrecht // Immunity. - 2015. - Vol. 43. - P. 29-40.73. Hammad H. Dendritic cells and epithelial cells: linking innate and adaptiveimmunity in asthma / H. Hammad, B.N. Lambrecht // Nat Rev Immunol. - 2008. - Vol.8.
- P. 193-204.74. Hamming O.J. Lambda Interferons: New Cytokines with Old Functions / O.J.Hamming, H.H. Gad, S. Paludan, R. Hartmann // Pharmaceuticals. - 2010. - Vol. 3. - Р.795-809.111 75. Hancock R.E. The immunology of host defence peptides: beyond antimicrobialactivity / R.E. Hancock, E.F. Haney, E.E. Gill // Nature Reviews Immunology. - 2016. Vol.
16. - № 5. - P. 321-334.76. Hatchwell L. Toll-like receptor 7 governs interferon and inflammatory responsesto rhinovirus and is suppressed by IL-5-induced lung eosinophilia / L. Hatchwell, A.Collison, J. Girkin, K. Parsons, J. Li, J. Zhang, S. Phipps, D. Knight, N.W. Bartlett, S.L.Johnston, P.S.
Foster, P.A. Wark, J. Mattes / Thorax. - 2015. - Vol. 70. - № 9. - P. 854861.77. Hedayat M. Prophylactic and therapeutic implications of toll-like receptor ligands/ M. Hedayat, K. Takeda, N. Rezaei // Med Res Rev. - 2012. - Vol. 32. - P. 294-325.78. Herr C. The role of cathelicidin and defensins in pulmonary inflammatorydiseases / C.
Herr, R. Shaykhiev, R. Bals // Expert Opin. Biol. Ther. - 2007. - Vol. 7. № 9. - P. 1449-1461.79. Hinks T. Multidimensional endotypes of asthma: topological data analysis ofcross-sectional clinical, pathological, and immunological data / T. Hinks, X. Zhou, K.Staples, B. Dimitrov, A. Manta, T. Petrossian, P. Lum, C. Smith, J.
Ward, P. Howarth,A. Walls, S.D. Gadola, R. Djukanović // Lancet. - 2015. - Vol. 385. - № suppl 1. - P. 42.80. Hirahara K. CD41 T-cell subsets in inflammatory diseases: beyond the Th1/Th2paradigm / K. Hirahara, T. Nakayama // Int Immunol. - 2016. - Vol. 28. - P. 163-171.81. Hollams E.M. Elucidation of asthma phenotypes in atopic teenagers throughparallel immunophenotypic and clinical profiling / E.M. Hollams, M.
Deverell, M.Serralha, D. Suriyaarachchi, F. Parsons, G. Zhang, N. de Klerk, B.J. Holt, C. Ladyman,A. Sadowska, J. Rowe, R. Loh, P.D. Sly, P.G. Holt // J Allergy Clin Immunol. - 2009. Vol. 124. - P. 463-470.82. Holgate S.T. Epithelium dysfunction in asthma / S.T. Holgate // Journal ofAllergy and Clinical Immunology. - 2007. - Vol. 120.
- P. 1233-1244.83. Hui C.C. T cell-mediated induction of thymic stromal lymphopoietin indifferentiated human primary bronchial epithelial cells / C.C. Hui, D.M. Murphy, H.Neighbour, M. Al-Sayegh, S. O’Byrne, B. Thong, J.A. Denburg, M. Larché // Clin ExpAllergy. - 2014. - Vol. 44. - №7. - P. 953-964.112 84. Hulse K.E.
Targeting allergen to FcgammaRI reveals a novel T(H)2 regulatorypathway linked to thymic stromal lymphopoietin receptor / K.E. Hulse, A.J. Reefer,V.H. Engelhard, J.T. Patrie, S.F. Ziegler, M.D. Chapman, J.A. Woodfolk // J AllergyClin Immunol. - 2010. - Vol. 125.
- №1. - P. 247-256.85. Hur J. The leukotriene receptor antagonist pranlukast attenuates airwayremodeling by suppressing TGF-β signaling / J. Hur, J.Y. Kang, C.K. Rhee, Y.K. Kim,S.Y. Lee // Pulm Pharmacol Ther. - 2018. - Vol. 48. - P. 5-14.86. Jackson D.J. The contributions of allergic sensitization and respiratory pathogensto asthma inception / D.J. Jackson, J.E. Gern, R.F. Jr Lemanske // J Allergy ClinImmunol. - 2016.
- Vol. 137. - P. 659-665.87. Jackson D.J. IL-33-dependent type 2 inflammation during rhinovirus-inducedasthma exacerbations in vivo / D.J. Jackson, H. Makrinioti, B.M. Rana, B.W. Shamji,M.B. Trujillo-Torralbo, J. Footitt, D.-R. Jerico, A.G. Telcian, A. Nikonova, J. Zhu, J.Aniscenko, L. Gogsadze, E. Bakhsoliani, S.
Traub, J. Dhariwal, J. Porter, D. Hunt, T.Hunt, T. Hunt, L.A. Stanciu, M. Khaitov, N.W. Bartlett, M.R. Edwards, O.M. Kon, P.Mallia, N.G. Papadopoulos, C.A. Akdis, J. Westwick, M.J. Edwards, D.J. Cousins, R.P.Walton, S.L. Johnston // Am J Respir Crit Care Med. - 2014. - Vol. 190. - №12. - P.1373-1382.88. Jackson D.J. The influence of asthma control on the severity of virus-inducedasthma exacerbations / D.J. Jackson, M.B. Trujillo-Torralbo, J. del-Rosario, N.W.Bartlett, M.R.
Edwards, P. Mallia,R.P Walton, S.L. Johnston // J Allergy ClinImmunol. - 2015. - Vol. 136. - P. 497-500.89. Jain V.V. CpG-oligodeoxynucleotides inhibit airway remodeling in a murinemodel of chronic asthma / V.V. Jain, K. Kitagaki, T. Businga Hussain I, C. George, P.O'shaughnessy, J.N.
Kline // Journal of Allergy and Clinical Immunology. - 2002. - Vol.110. - № 6. - P. 867-872.90. Jang J. An overview of pathogen recognition receptors for innate immunity indental pulp / J. Jang, H. W. Shin, J. M. Lee, H. Lee, E. Kim, S. H. Park // Mediators ofInflammation. - 2015.
- Vol. 2015. - Article ID 794143.113 91. Johansson S.G. A revised nomenclature for allergy. An EAACI positionstatement from the EAACI nomenclature task force / S.G. Johansson, J.O. Hourihane, J.Bousquet, C. Bruijnzeel-Koomen, S. Dreborg, T. Haahtela, M.L. Kowalski, N.
Mygind,J. Ring, P. van Cauwenberge, M. van Hage-Hamsten, B. Wüthrich; EAACI (theEuropean Academy of Allergology and Cinical Immunology) nomenclature task force //Allergy. - 2001. - Vol. 56. - №9. - P. 813-824.92. Jutel M. IL-10 and TGF-βeta cooperate in the regulatory T cell response tomucosal allergens in normal immunity and specific immunotherapy / M. Jutel, M.Akdis, F. Budak, C. Aebischer-Casaulta, M.
Wrzyszcz, K. Blaser, CA. Akdis // Eur JImmunol. - 2003. - Vol. 33. - № 5. - P. 1205-1214.93. Ioannidis I. Toll-like receptor expression and induction of type I and type IIIinterferons in primary airway epithelial cells / I. Ioannidis, F. Ye, B. McNally, M.Willette, E. Flan ̃o // Journal of Virology. - 2013.
- Vol. 87. - № 6. - P. 3261-3270.94. Islam S.A. T cell homing to epithelial barriers in allergic disease / S.A. Islam,A.D. Luster // Nature medicine. - 2012. - Vol. 18. - № 5. - P. 705-715.95. Ito K. Updateonglucocorticoid action and resistance / K. Ito, K.F. Chung, I.M.Adcock // Journal of Allergy and Clinical Immunology. - 2006. - Vol. 117. - № 3.
- P.522-543.96. Ito T. TSLP- activated dendritic cells induce an inflammatory T helper type 2 cellresponse through OX40 ligand / T. Ito, Y.H. Wang, O. Duramad, T. Hori, G.J.Delespesse, N. Watanabe, F.X. Qin, Z. Yao, W. Cao, Y.J. Liu // J Exp Med. - 2005. Vol. 202. - № 9. - P. 1213-1223.97. Kamali-Sarvestani E. Association of TNF-alpha -308 G/A and IL-4 -589 C/Tgene promoter polymorphisms with asthma susceptibility in the south of Iran / E.Kamali-Sarvestani, M.A. Ghayomi, A. Nekoee // J Investig. Allergol. Clin. Immunol. 2007.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
